Open AccessS219: FIRST CLINICAL STUDY OF THE ANTI‐SIGNAL REGULATORY PROTEIN‐ALPHA (SIRPΑ) ANTIBODY CC‐95251 COMBINED WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)
Author(s) -
Strati P.,
Hawkes E.,
Ghosh N.,
Tuscano J.,
Chu Q.,
Anderson M. A.,
Patel A.,
Burgess M. R.,
Hege K.,
Chhagan S.,
Boyanapalli S.,
Day T.,
Shen F.,
Mehta A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843768.58631.ac
Subject(s) - medicine , rituximab , cd47 , antibody , lymphoma , tolerability , radioimmunotherapy , calicheamicin , cd20 , anemia , cancer research , immunology , pharmacology , oncology , monoclonal antibody , adverse effect